|
9th Influenza Conference 2023
Communication: Raising awareness on the burden of disease
SPI06 session from #ESWI2023
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males
|
9th Influenza Conference 2023
Intervention strategies for the management of ARVI
SPI05 session from #ESWI2023
|
9th Influenza Conference 2023
Novel Approach For An Evolution-Proof Influenza Vaccine
POSTER 403 from #ESWI2023
|
9th Influenza Conference 2023
Science based preparedness for and management of epidemic and pandemics
Report of session at #ESWI2023
|
9th Influenza Conference 2023
ESWI Symposium: RSV Looking towards the future
SPI07 session from #ESWI2023
|
9th Influenza Conference 2023
Unveiling the Roles of Metabolism and Genetics
Cracking the code of severe disease
|
9th Influenza Conference 2023
Investigating the Antigenic Evolution of Influenza B Viruses and RSV
How respiratory viruses can change
|
9th Influenza Conference 2023
Best practices in vaccination programmes for risk groups and healthcare workers
SPI03 session from #ESWI2023
|
9th Influenza Conference 2023
Why influenza and RSV disease are a priority for policy makers
SPI01 session from #ESWI2023